The University of Chicago Header Logo

Connection

John Moroney to Everolimus

Back to Details
This is a "connection" page, showing publications John Moroney has written about Everolimus.
John Moroney
Connection Strength
0.052
Everolimus
  1. A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. Gynecol Oncol. 2022 03; 164(3):481-491.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.